MX9204517A - Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia. - Google Patents

Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.

Info

Publication number: MX9204517A
Authority: MX; Mexico
Prior art keywords: microsurgery; derivatives; hyaluronic acid; essentially formed; material essentially
Prior art date: 1991-08-05

Application number

MX9204517A

Other languages

English (en)

Inventor

Alberto Perbellini

Gino Toffano

Aurelio Romeo

Original Assignee

Fidia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-05

Filing date

1992-08-04

Publication date

1993-03-01

1992-08-04 Application filed by Fidia Spa filed Critical Fidia Spa

1993-03-01 Publication of MX9204517A publication Critical patent/MX9204517A/es

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000000463 material Substances 0.000 title 1
238000002406 microsurgery Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/05—Elimination by evaporation or heat degradation of a liquid phase
- C08J2201/0504—Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/07—Microporous membranes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Polymers & Plastics (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Materials For Medical Uses (AREA)

MX9204517A 1991-08-05 1992-08-04 Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia. MX9204517A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI912207A IT1251151B (it)	1991-08-05	1991-08-05	Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati

Publications (1)

Publication Number	Publication Date
MX9204517A true MX9204517A (es)	1993-03-01

Family

ID=11360538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9204517A MX9204517A (es)	1991-08-05	1992-08-04	Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.

Country Status (10)

Country	Link
US (1)	US5503848A (es)
EP (1)	EP0526865A1 (es)
JP (1)	JPH05255124A (es)
KR (1)	KR930003921A (es)
AU (1)	AU654027B2 (es)
BR (1)	BR9203032A (es)
CA (1)	CA2075340A1 (es)
IT (1)	IT1251151B (es)
MX (1)	MX9204517A (es)
TW (1)	TW215903B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1260154B (it) *	1992-07-03	1996-03-28	Lanfranco Callegaro	Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
IT1263144B (it) *	1993-02-04	1996-08-01	Lanfranco Callegaro	Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
US6130264A (en) *	1994-10-06	2000-10-10	Xomed Surgical Products, Inc.	Synthetic sponge and surgical spear comprising synthetic sponge
US6080092A (en) *	1994-10-06	2000-06-27	Xomed Surgical Products, Inc.	Industrial cleaning sponge
IT1282207B1 (it) *	1995-11-20	1998-03-16	Fidia Advanced Biopolymers Srl	Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
US6099952A (en) *	1998-02-18	2000-08-08	Xomed Surgical Products, Inc.	Medical sponge having mucopolysaccharide coating
US5976150A (en) *	1998-08-25	1999-11-02	Alcon Laboratories, Inc.	Intraocular lens injection system
US6120484A (en) *	1999-02-17	2000-09-19	Silverstein; Herbert	Otological implant for delivery of medicament and method of using same
EP1369441A4 (en) *	2001-01-31	2004-12-08	Seikagaku Kogyo Co Ltd	NETWORKED POLYSACCHARIDE SPONGE
US7923431B2 (en) *	2001-12-21	2011-04-12	Ferrosan Medical Devices A/S	Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
BRPI0312669B8 (pt) *	2002-08-07	2021-05-25	Laboratoire Medidom S A	processo para preparo de uma formulação farmacêutica aquosa estéril pronta para uso
BR0317237A (pt) *	2002-12-11	2005-11-01	Ferrosan As	Dispositivo para amostragem ou coleta, kit, usos de um dispositivo e de um kit, e, métodos para diminuir a quantidade de um marcador em uma área de amostra, para amostrar de modo qualitativo ou quantitativo uma área quanto ao teor de um marcador e para cultivar microorganismos ou células de mamìferos coletados
WO2005072700A2 (en) *	2004-01-30	2005-08-11	Ferrosan A/S	Haemostatic sprays and compositions
US8021684B2 (en) *	2004-07-09	2011-09-20	Ferrosan Medical Devices A/S	Haemostatic composition comprising hyaluronic acid
JP2006342207A (ja) *	2005-06-07	2006-12-21	Toshiba Corp	発泡材料組成物、発泡材料、および発泡材料の再生方法
WO2008027904A2 (en) *	2006-08-28	2008-03-06	Rexaderm, Inc.	Dry wound dressing and drug delivery system
US8257455B2 (en)	2007-07-30	2012-09-04	Korea Institute Of Machinery & Materials	Plasma burner and diesel particulate filter trap
US8642831B2 (en) *	2008-02-29	2014-02-04	Ferrosan Medical Devices A/S	Device for promotion of hemostasis and/or wound healing
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
EP2278999B1 (en)	2008-04-21	2025-01-29	Dompé farmaceutici S.p.A.	Auris formulations for treating otic diseases and conditions
CA2723458C (en)	2008-05-14	2014-01-28	Otonomy, Inc.	Controlled release corticosteroid compositions and methods for the treatment of otic disorders
US8648119B2 (en) *	2008-05-23	2014-02-11	Otonomy, Inc.	Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en) *	2008-06-18	2014-09-30	Otonomy, Inc.	Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US8349353B2 (en) *	2008-06-27	2013-01-08	Otonomy, Inc.	Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
WO2010011466A2 (en)	2008-06-27	2010-01-28	Otonomy, Inc.	Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US20100016218A1 (en) *	2008-07-14	2010-01-21	Otonomy, Inc.	Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
EP2306975A4 (en) *	2008-07-21	2012-10-31	Otonomy Inc	COMPOSITIONS WITH A TAXED RELEASE FOR MODULATING THE EARM STRUCTURE AND THE BORN IMMUNE SYSTEM, AND METHODS OF TREATING EAR OR DISEASE
US8399018B2 (en) *	2008-07-21	2013-03-19	Otonomy, Inc.	Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US20100016450A1 (en) *	2008-07-21	2010-01-21	Otonomy, Inc.	Controlled release delivery devices for the treatment of otic disorders
US8496957B2 (en)	2008-07-21	2013-07-30	Otonomy, Inc	Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
US8784870B2 (en)	2008-07-21	2014-07-22	Otonomy, Inc.	Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US8318817B2 (en)	2008-07-21	2012-11-27	Otonomy, Inc.	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
EP2344151A4 (en)	2008-10-22	2012-04-18	House Ear Inst	TREATMENT AND / OR PREVENTION OF INTERNAL ELEMENTS BY MODULATION OF A METABOTROPIC GLUTAMATE RECEPTOR
JP5620387B2 (ja) *	2009-09-02	2014-11-05	テルモ株式会社	多孔質構造体
US11109849B2 (en)	2012-03-06	2021-09-07	Ferrosan Medical Devices A/S	Pressurized container containing haemostatic paste
BR112014030962A2 (pt)	2012-06-12	2017-06-27	Ferrosan Medical Devices As	métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
US20150252120A1 (en)	2012-10-09	2015-09-10	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Modified hyaluronic acid derivatives and use thereof
EP3010419B1 (en)	2013-06-21	2020-05-20	Ferrosan Medical Devices A/S	Vacuum expanded dry composition and syringe for retaining same
KR20160047490A (ko)	2013-08-27	2016-05-02	오토노미, 인코포레이티드	소아 귀 질환의 치료
JP6489485B2 (ja)	2013-12-11	2019-03-27	フェロサンメディカルデバイシーズエイ／エス	押し出し増強因子を含んでいる乾燥組成物
EP3206726B1 (en)	2014-10-13	2020-05-27	Ferrosan Medical Devices A/S	Dry composition for use in haemostasis and wound healing
CN107206165B (zh)	2014-12-24	2020-10-23	弗罗桑医疗设备公司	用于保持并混合第一和第二物质的注射器
JP6747651B2 (ja)	2015-07-03	2020-08-26	フェロサンメディカルデバイシーズエイ／エス	保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
KR102426461B1 (ko)	2016-07-27	2022-07-29	가부시키가이샤 리타파마	구강 점막 부착재 및 그의 제조 방법
EP3512513A4 (en)	2016-09-16	2020-04-15	Otonomy, Inc.	OTIC GEL FORMULATIONS FOR THE TREATMENT OF EXTERNAL OTITIS
WO2019215274A1 (en)	2018-05-09	2019-11-14	Ferrosan Medical Devices A/S	Method for preparing a haemostatic composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2915309A1 (de) *	1979-04-14	1980-10-30	Behringwerke Ag	Verfahren zur bestimmung von anti-hyaluronidase und hierfuer verwendbares mittel
US4490351A (en) *	1982-03-15	1984-12-25	Children's Hospital Medical Center	Methods of treating disorders of an eye with liquid perfluorocarbons
CH666897A5 (fr) *	1983-10-11	1988-08-31	Fidia Spa	Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
MX163953B (es) *	1984-03-27	1992-07-03	Univ New Jersey Med	Procedimiento para preparar una matriz biodegradable a base de colageno
SE8501022L (sv) *	1985-03-01	1986-09-02	Pharmacia Ab	Format alster och forfarande for dess framstellning
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
DK505488D0 (da) *	1987-12-21	1988-09-09	Bar Shalom Daniel	Middel og anvendelse af samme
FR2650180B1 (fr) *	1989-07-31	1995-03-03	Chisso Corp	Procede de production d'une feuille facilement soluble dans l'eau a base d'acide hyaluronique ou de hyaluronate et feuille ainsi obtenue

1991
- 1991-08-05 IT ITMI912207A patent/IT1251151B/it active IP Right Grant
1992
- 1992-08-03 TW TW081106130A patent/TW215903B/zh active
- 1992-08-03 EP EP92113212A patent/EP0526865A1/en not_active Ceased
- 1992-08-04 BR BR929203032A patent/BR9203032A/pt not_active Application Discontinuation
- 1992-08-04 JP JP4207881A patent/JPH05255124A/ja active Pending
- 1992-08-04 KR KR1019920013969A patent/KR930003921A/ko not_active Withdrawn
- 1992-08-04 MX MX9204517A patent/MX9204517A/es unknown
- 1992-08-05 CA CA002075340A patent/CA2075340A1/en not_active Abandoned
- 1992-08-05 US US07/925,073 patent/US5503848A/en not_active Expired - Lifetime
- 1992-08-05 AU AU20840/92A patent/AU654027B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP0526865A1 (en)	1993-02-10
CA2075340A1 (en)	1993-02-06
US5503848A (en)	1996-04-02
TW215903B (es)	1993-11-11
AU2084092A (en)	1993-02-11
IT1251151B (it)	1995-05-04
AU654027B2 (en)	1994-10-20
KR930003921A (ko)	1993-03-22
ITMI912207A0 (it)	1991-08-05
BR9203032A (pt)	1993-03-30
ITMI912207A1 (it)	1993-02-05
JPH05255124A (ja)	1993-10-05

Publication	Publication Date	Title
MX9204517A (es)	1993-03-01	Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.
DE69021282D1 (de)	1995-09-07	Prepolymere zur Verwendung in biomedizinischen Vorrichtungen.
FI962589L (fi)	1996-08-20	2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
NO905532D0 (no)	1990-12-21	Vandig beleggsmateriale for utvendige overflater.
NO902111D0 (no)	1990-05-11	Cyklopropylalkyl- eller -alkenylforbindelser, fremgangsmaate for deres fremstilling og anvendelse derav i flytende krystallinske blandinger.
DK1590D0 (da)	1990-01-04	Protease-deficiente gram-positive bakterier og deres anvendelse som vaertsorganismer til produktion af rekombinante produkter
MX9102630A (es)	1992-06-01	Derivados de benzamida y proceso para su preparacion.
NO894725D0 (no)	1989-11-27	Mineralfiber-basert komposittmateriale, innretning for fremstilling derav og materialets anvendelse.
DE68913090D1 (de)	1994-03-24	Modifizierter menschlicher PSTI.
DE69230825D1 (de)	2000-04-27	Genexpression in bazillen
NO923248L (no)	1994-02-21	Sprengstoff for anvendelse i bulk eller patronert form
NO911262D0 (no)	1991-03-27	Lettvektsement for anvendelse i omgivelser med hoeyt trykk.
FI882254A7 (fi)	1988-11-16	Oksi-iminoeetteriyhdisteitä, niiden käyttö rikkaruohomyrkkyinä, sekä niiden valmistus ja valmistuksessa käytettävät välituotteet
FI930522A0 (fi)	1993-02-05	Kaasunkeräysyksikkö
NO924516D0 (no)	1992-11-24	Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler
NO892190L (no)	1989-12-04	Kompositt-materialer og deres anvendelse.
NO893925L (no)	1990-05-07	1-metyl-3, 5, 7-triaza-1-azoniatricyklodekan trijodid, fremgangsmaate for fremstilling derav, og anvendelse derav ved bekjempelse av mikroorganismer i vandige systemer.
TR24169A (tr)	1991-05-01	Benzohidroksamik tuerevleri, bunlarin herbisitler olarak kullanilmasi vebunlari
BR7002426U (pt)	1992-07-07	Disposicoes introduzidas em agenda para aficionados de cinevideo
ES517956A0 (es)	1983-11-16	Disposicion perfeccionada para el tallado de objetos de vidrio y similares.
NO905110L (no)	1991-05-29	Forbedringer i forbindelse med egenskapene til cellulosefiber-baserte papirark.
NO900275L (no)	1990-07-23	Benzopyranderivater, deres fremstilling og anvendelse i legemidler.
ITRM920415A1 (it)	1993-12-01	Composizione per uso chirurgico e sua applicazine per irrigazioni chirurgiche.
DK395989D0 (da)	1989-08-11	Praeparat til konservering af mikrobielt fordaervelige produkter, dets fremstiling og anvendelse
FI893866A7 (fi)	1990-02-19	N-sulfonometyyliglysinaatti, menetelmä sen valmistamiseksi ja sen käyttö glyfosfaattityyppisten herbisidien valmistuksessa